LV Dysfunction

9 registered clinical trials studyying LV Dysfunction — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor NCT06699056	Peerbridge Health, Inc	—
Recruiting	Study to Assess Safety and Efficacy of Treating Symptomatic, Ischemic, Chronic Congestive Heart Failure Patien NCT06705023	Ralf Rothoerl	Phase 2
Enrolling By Invitation	COR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications Usi NCT06763549	Peerbridge Health, Inc	—
Not Yet Recruiting	Midodrine in Heart Failure With Reduced Ejection Fraction With Hypotension NCT06405555	Ottawa Heart Institute Research Corporation	Phase 2 / Phase 3
Not Yet Recruiting	Coronary Artery Bypass Grafts or Percutaneous Coronary Intervention for High Risk Patients NCT05534698	Danish Study Group	N/A
Completed	Pediatric Ventricle Function Assessment Study NCT06739057	HBI Solutions Inc.	—
Terminated	Early Detection of Cardiac Toxicity of Trastuzumab (Herceptin ®) in Patients Treated for Breast Carcinoma: Val NCT01436604	Centre Francois Baclesse	Phase 2
Terminated	Dual Site Left Ventricular (LV) Pacing NCT00944125	Wake Forest University Health Sciences	N/A
Completed	Study to Compare TWA Test and EPS Test for Predicting Patients at Risk for Life-threatening Heart Rhythms (ABC NCT00187291	Abbott Medical Devices	Phase 3